BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29655687)

  • 1. The inhibitory potential of Broussochalcone A for the human cytochrome P450 2J2 isoform and its anti-cancer effects via FOXO3 activation.
    Park SH; Lee J; Shon JC; Phuc NM; Jee JG; Liu KH
    Phytomedicine; 2018 Mar; 42():199-206. PubMed ID: 29655687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plant natural product plumbagin presents potent inhibitory effect on human cytochrome P450 2J2 enzyme.
    Lu J; Liu D; Zhou X; Chen A; Jiang Z; Ye X; Liu M; Wang X
    Phytomedicine; 2018 Jan; 39():137-145. PubMed ID: 29433675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of acetylshikonin as the novel CYP2J2 inhibitor with anti-cancer activity in HepG2 cells.
    Park SH; Phuc NM; Lee J; Wu Z; Kim J; Kim H; Kim ND; Lee T; Song KS; Liu KH
    Phytomedicine; 2017 Jan; 24():134-140. PubMed ID: 28160853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential of decursin to inhibit the human cytochrome P450 2J2 isoform.
    Lee B; Wu Z; Sung SH; Lee T; Song KS; Lee MY; Liu KH
    Food Chem Toxicol; 2014 Aug; 70():94-9. PubMed ID: 24788058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of cytochrome P450 2J2 by tanshinone IIA induces apoptotic cell death in hepatocellular carcinoma HepG2 cells.
    Jeon YJ; Kim JS; Hwang GH; Wu Z; Han HJ; Park SH; Chang W; Kim LK; Lee YM; Liu KH; Lee MY
    Eur J Pharmacol; 2015 Oct; 764():480-488. PubMed ID: 26209360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Danazol Inhibits Cytochrome P450 2J2 Activity in a Substrate-independent Manner.
    Lee E; Wu Z; Shon JC; Liu KH
    Drug Metab Dispos; 2015 Aug; 43(8):1250-3. PubMed ID: 26048912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Broussochalcone A Induces Apoptosis in Human Renal Cancer Cells via ROS Level Elevation and Activation of FOXO3 Signaling Pathway.
    Lee HK; Cha HS; Nam MJ; Park K; Yang YH; Lee J; Park SH
    Oxid Med Cell Longev; 2021; 2021():2800706. PubMed ID: 34745413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of CYP2J2 on the intestinal first-pass metabolism of antihistamine drug, astemizole.
    Matsumoto S; Hirama T; Matsubara T; Nagata K; Yamazoe Y
    Drug Metab Dispos; 2002 Nov; 30(11):1240-5. PubMed ID: 12386130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro characterization of 4'-(p-toluenesulfonylamide)-4-hydroxychalcone using human liver microsomes and recombinant cytochrome P450s.
    Lee B; Wu Z; Lee T; Tan XF; Park KH; Liu KH
    Xenobiotica; 2016; 46(4):350-6. PubMed ID: 26330107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity.
    Lee CA; Jones JP; Katayama J; Kaspera R; Jiang Y; Freiwald S; Smith E; Walker GS; Totah RA
    Drug Metab Dispos; 2012 May; 40(5):943-51. PubMed ID: 22328583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LKY-047: First Selective Inhibitor of Cytochrome P450 2J2.
    Phuc NM; Wu Z; O Y; Lee JH; Oh S; Song GY; Liu KH
    Drug Metab Dispos; 2017 Jul; 45(7):765-769. PubMed ID: 28461575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Terfenadone is a strong inhibitor of CYP2J2 present in the human liver and intestinal microsomes.
    Lee E; Kim JH; Shon JC; Wu Z; Kim HJ; Gim M; Lee T; Liu KH
    Drug Metab Pharmacokinet; 2018 Jun; 33(3):159-163. PubMed ID: 29759885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective inhibitory effects of machilin A isolated from Machilus thunbergii on human cytochrome P450 1A and 2B6.
    Kim SJ; You J; Choi HG; Kim JA; Jee JG; Lee S
    Phytomedicine; 2015 Jun; 22(6):615-20. PubMed ID: 26055126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 6,8-Diprenylorobol Induces Apoptosis in Human Hepatocellular Carcinoma Cells via Activation of FOXO3 and Inhibition of CYP2J2.
    Lee CM; Lee J; Jang SN; Shon JC; Wu Z; Park K; Liu KH; Park SH
    Oxid Med Cell Longev; 2020; 2020():8887251. PubMed ID: 33312341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of CYP2J2 and CYP4F12 in the metabolism of ebastine in human intestinal microsomes.
    Hashizume T; Imaoka S; Mise M; Terauchi Y; Fujii T; Miyazaki H; Kamataki T; Funae Y
    J Pharmacol Exp Ther; 2002 Jan; 300(1):298-304. PubMed ID: 11752129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetylshikonin is a novel non-selective cytochrome P450 inhibitor.
    Shon JC; Phuc NM; Kim WC; Heo JK; Wu Z; Lee H; Liu KH
    Biopharm Drug Dispos; 2017 Dec; 38(9):553-556. PubMed ID: 28866862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular determinant of substrate binding and specificity of cytochrome P450 2J2.
    Xu L; Chen LY
    Sci Rep; 2020 Dec; 10(1):22267. PubMed ID: 33335233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of antihypertensive drugs on human cytochrome P450 2J2 activity: Potent inhibition by azelnidipine and manidipine.
    Ikemura N; Yamaori S; Kobayashi C; Kamijo S; Murayama N; Yamazaki H; Ohmori S
    Chem Biol Interact; 2019 Jun; 306():1-9. PubMed ID: 30965050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of novel substrates for human cytochrome P450 2J2.
    Lee CA; Neul D; Clouser-Roche A; Dalvie D; Wester MR; Jiang Y; Jones JP; Freiwald S; Zientek M; Totah RA
    Drug Metab Dispos; 2010 Feb; 38(2):347-56. PubMed ID: 19923256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening of ten cytochrome P450 enzyme activities with 12 probe substrates in human liver microsomes using cocktail incubation and liquid chromatography-tandem mass spectrometry.
    Kim HJ; Lee H; Ji HK; Lee T; Liu KH
    Biopharm Drug Dispos; 2019 Apr; 40(3-4):101-111. PubMed ID: 30730576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.